정위적 신경 내비게이션 시스템 시장 - 세계 및 지역별 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 분석과 예측(2025-2035년)

This report can be delivered within 1 working day.

Introduction of Stereotactic Neuro-Navigation System Market

The global stereotactic neuro-navigation system market, initially valued at $840.7 million in 2024, is projected to witness substantial growth, surging to $3,100.3 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 12.92% over the period from 2025 to 2035.

The market has been witnessing double-digit growth, driven by the rising prevalence of neurological disorders, benefits offered by navigation-assisted surgeries over conventional surgeries, and a shift toward minimally invasive surgery.

Technological advancements, including the integration of artificial intelligence (AI), machine learning (ML), and augmented reality (AR), have been enhancing surgical precision and expanding the capabilities of these systems. Additionally, the increasing adoption of minimally invasive surgery (MIS) has been driving the demand for more advanced and accurate navigation tools. The market is also bolstered by a growing aging population, leading to an increase in age-related neurological conditions that require surgical treatment. However, challenges such as the high cost of these systems, integration complexities, and potential complications during surgery may hinder market growth. Despite these challenges, ongoing innovation, favorable regulatory support, and expanding applications in neurosurgery and other specialties are expected to fuel continued market expansion.

Market Introduction

The stereotactic neuro-navigation system market has been rapidly advancing, driven by technological innovations and strategic collaborations that enhance surgical precision and patient outcomes. Partnerships, such as Medtronic's collaboration with Brainlab, have been pioneering integrated navigation solutions that combine real-time imaging with advanced surgical planning, thereby improving accuracy in neurosurgical procedures. Meanwhile, companies such as Orthofix Medical have been expanding their portfolio through the development of neuro-navigation system, facilitating minimally invasive spine surgeries. Recent product launches, including Stryker's Cranial Navigation System, offer enhanced visualization and augmented reality features that support complex tumor resections. Additionally, acquisitions such as Brainlab's acquisition of Novalis Circle are consolidating expertise and technology, positioning the market for robust growth. These developments underscore the increasing demand for precision neurosurgery tools, driving innovation and expanding clinical applications in the field.

Industrial Impact

The global stereotactic neuro-navigation system market, driven by industry leaders such as Medtronic, Brainlab, Stryker, and Orthofix Medical Inc., has been transforming the landscape of neurosurgical interventions. By integrating advanced imaging modalities such as MRI and CT with real-time navigation, these companies provide comprehensive solutions for precise brain surgeries, including tumor resections, deep brain stimulation, and epilepsy treatment. Products such as Medtronic's StealthStation and Brainlab's Curve Navigation System exemplify this technological integration, enhancing surgical accuracy and reducing operative risks. The industrial impact extends across clinical neurosurgery, research, and training, facilitating minimally invasive procedures and improving patient outcomes. Through continuous innovation and expanding clinical applications, the stereotactic neuro-navigation market has been driving significant advancements in neurosurgical care globally.

Market Segmentation:

Segmentation 1: by Product

• Neuro-Navigation System
• Stereotactic Frame Units

Neuro-Navigation Systems Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Product)

Based on product, the global stereotactic neuro-navigation system market was led by the neuro-navigation system, which held an 80.9% share in 2024. The segment dominates the market primarily due to its advanced technological capabilities, enhanced precision, and increased versatility in modern surgical practices. Neuro-navigation systems utilize real-time 3D imaging and advanced integration with modalities such as MRI, CT scans, and ultrasound to provide precise, dynamic guidance during surgery. This offers superior accuracy in targeting and navigating complex areas of the brain and spinal cord, which is essential for minimizing complications and improving patient outcomes.

Segmentation 2: by Application

• Cranial
• Spinal

Spinal Segment to Dominate the Stereotactic Neuro-Navigation System Market (by Application)

Based on application type, the global stereotactic neuro-navigation system market was led by the spinal segment, which held a 62.6% share in 2024. Spinal applications dominate the neuro-navigation system market due to the higher incidence of spinal conditions, such as degenerative diseases, spinal deformities, and trauma, which require frequent surgical intervention. The increasing adoption of minimally invasive spine surgery (MISS) further drives demand, as these procedures require enhanced precision, which neuro-navigation systems provide. Additionally, the complexity of spinal surgeries, combined with the growing aging population facing age-related spinal issues, contributes to the greater utilization of spinal navigation systems. These factors collectively make spinal applications the leading segment in the market over cranial applications.

Segmentation 3: by End User

• Hospitals
• ASCs

Hospital Segment to Dominate the Stereotactic Neuro-Navigation System Market (by End User)

Based on end user, the global stereotactic neuro-navigation system market was led by the hospital segment, which held a 91.9% share in 2024. Hospitals dominate the neuro-navigation system market based on end-users due to their central role in providing comprehensive surgical care and their capacity to handle complex and high-volume surgeries. Hospitals, especially academic medical centers, and large healthcare facilities, are equipped with advanced infrastructure, skilled medical professionals, and specialized departments such as neurosurgery, orthopedics, and spinal surgery, which drive the demand for neuro-navigation systems. These systems are essential for performing precise, minimally invasive surgeries, thereby improving patient outcomes and reducing recovery times, all of which are crucial for hospitals striving to deliver the best care. Additionally, hospitals generally conduct a higher volume of surgeries, ranging from routine to complex procedures, which further contributes to their market dominance. The ability of hospitals to invest in cutting-edge technology and adopt multi-specialty applications of navigation systems makes them key players in the growth of this market.

Segmentation 4: by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Rest-of-Europe
• Asia-Pacific
  • Japan
  • China
  • Rest-of-Asia-Pacific
• Rest-of-the-World

The stereotactic neuro-navigation system market in the North America region is expected to witness a significant growth rate of 12.36% during the forecast period. This notable growth can be attributed to several key factors, including advanced healthcare infrastructure, high adoption of innovative technologies, and strong research and development capabilities. The region is home to some of the world's leading hospitals, medical centers, and academic institutions, which are equipped with state-of-the-art facilities and highly skilled professionals. This infrastructure facilitates the adoption of cutting-edge technologies such as neuro-navigation systems. Additionally, North America has a high prevalence of spinal and cranial conditions, which increases the demand for precise surgical interventions. The region's healthcare system, which provides wide access to advanced treatments, drives the use of minimally invasive surgeries where neuro-navigation is essential. Furthermore, the U.S. and Canada have robust regulatory environments and strong support for innovation, with companies such as Medtronic and Stryker leading the development of neuro-navigation technologies, thereby further cementing North America's leadership in this market.

Recent Developments in the Stereotactic Neuro-Navigation System Market

• In September 2024, Stryker Corporation acquired NICO Corporation, a privately held firm offering a systematic approach to minimally invasive surgery for tumor and intracerebral hemorrhage (ICH) procedures. This acquisition reinforces Stryker's commitment to neurotechnology, particularly in tumor and stroke care.
• In May 2024, AiM Robotics partnered with Synaptive Medical to integrate the Modus Nav neuro-navigation software into its neurosurgery robot, improving visualization, navigation, and control.
• In July 2023, Stryker Corporation launched the Q Guidance System with Cranial Guidance Software.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

• Rising Prevalence of Neurological Disorder: The rising prevalence of neurological disorders is a significant driver of the stereotactic neuro-navigation market. As the global incidence of conditions such as brain tumors, epilepsy, and Parkinson's disease increases, the demand for precise surgical interventions has escalated. For instance, as per the Health Data, around 3.40 billion individuals had conditions affecting the nervous system in 2021. Stereotactic neuro-navigation systems, which offer high accuracy and minimal invasiveness, are increasingly utilized to address these challenges. Moreover, neurological conditions are the number one leading cause of disease burden worldwide. Moreover, the global population has been aging, leading to an increase in age-related neurological conditions. This demographic shift is contributing to a higher demand for neurosurgical interventions and, consequently, for advanced neuro-navigation technologies. As the global population ages, the incidence of age-related neurological diseases, such as dementia and Parkinson's disease, rises. This contributes to a larger patient base requiring surgical intervention for these conditions. As the demand for surgical treatments increases, so does the demand for accurate, reliable neuro-navigation systems to guide these complex procedures.

Market Challenges:

• Complications Associated with the Use of Navigation Systems: While neuro-navigation systems have revolutionized neurosurgery by enhancing precision, safety, and efficiency, their use does not come without complications. Like any advanced technology, the integration of navigation systems in neurosurgery has its challenges. In navigation-assisted neuro surgeries, while entry points and trajectories for instrumentation are clearly defined, inaccuracies may arise during screw insertion due to manual tapping or insertion, leading to wobbling and maximal radial movement from the center of the axis. To mitigate this, it is advisable to delay screw insertion until after all planned trajectories have been created. Presently, powered pedicle screw drive systems are available, offering faster and more accurate screw insertions, thereby enhancing the surgeon's experience.

Market Opportunities:

• Integration of Artificial Intelligence (AI) and Machine Learning: AI and machine learning (ML) techniques present significant opportunities for integration within neurosurgery, offering transformative capabilities. These technologies are pivotal in several key applications, including the segmentation of intraoperative images to enhance navigation systems, especially in the precise placement of pedicle screws. Moreover, ML algorithms play a vital role in the interpretation of images depicting intervertebral discs or full spine radiographs, facilitating automation and streamlining diagnostic procedures for clinicians. Furthermore, the integration of virtual reality (VR) and augmented reality (AR) systems into surgical training programs has already shown promising outcomes. These advanced technologies provide immersive learning experiences for trainees, enabling them to simulate surgical procedures in realistic virtual environments. Studies have indicated that such immersive training correlates with improved operative times and overall performance among trainees, underscoring the value of VR and AR in enhancing surgical education and proficiency.

How can this report add value to an organization?

Product/Innovation Strategy: The global stereotactic neuro-navigation system market has been extensively segmented based on various categories, such as product application area, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Partnerships, alliances, and collaborations accounted for the maximum number of key developments, i.e., nearly 35.0% of the total developments in the global stereotactic neuro-navigation system market were between January 2020 and April 2025.

Competitive Strategy: The global stereotactic neuro-navigation system market has numerous established players with product portfolios. Key players in the global stereotactic neuro-navigation system market analyzed and profiled in the study include established players offering products for stereotactic neuro-navigation systems.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2020-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report presents a comprehensive market study of the upstream and downstream products in the stereotactic neuro-navigation system market.
• The market contribution of stereotactic neuro-navigation systems is anticipated to be launched in the future and has been calculated based on the historical analysis of the solutions.
• Revenues of the companies have been referenced from their annual reports for FY2023 and FY2024. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
• The market has been mapped based on the available stereotactic neuro-navigation systems. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in stereotactic neuro-navigation systems, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Validation of the numbers of the different segments of the market in focus
• Percentage split of individual markets for regional analysis

Secondary Research:

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles

Paid databases

The key data points taken from the secondary sources include:

• Segmentations and percentage shares
• Data for market value
• Key industry trends of the top players of the market
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Medtronic Plc
• Brainlab AG
• ClearPoint Neuro, Inc.
• Elekta
• Stryker Corporation
• Orthofix Medical Inc.
• Saphirex Surgicals
• FHC
• Integra LifeSciences Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

• 1.1 Market Trends
  • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
• 1.2 Reimbursement Scenario
• 1.3 Patent Analysis
• 1.4 Regulatory Landscape/Compliance
  • 1.4.1 U.S.
  • 1.4.2 Europe
    • 1.4.2.1 U.K.
  • 1.4.3 Japan
  • 1.4.4 China
  • 1.4.5 Rest-of-the-World (RoW)
• 1.5 Supply Chain Analysis
• 1.6 Pricing Analysis
• 1.7 Market Dynamics
  • 1.7.1 Market Drivers
    • 1.7.1.1 Rising Prevalence of Neurological Disorders
    • 1.7.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
  • 1.7.2 Market Restraints
    • 1.7.2.1 Complications Associated with the Use of Navigation Systems
    • 1.7.2.2 High Cost of Acquisition
  • 1.7.3 Market Opportunities
    • 1.7.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Global Stereotactic Neuro-navigation System Market (By Product), $Million, 2023-2035

• 2.1 Neuro-Navigation System
  • 2.1.1 Stealth Station Navigation
    • 2.1.1.1 Overview
    • 2.1.1.2 Installed Base
    • 2.1.1.3 Average Selling Price
    • 2.1.1.4 Unit Sold
    • 2.1.1.5 Market Sizing and Forecast
  • 2.1.2 Curve Navigation
    • 2.1.2.1 Overview
    • 2.1.2.2 Installed Base
    • 2.1.2.3 Average Selling Price
    • 2.1.2.4 Unit Sold
    • 2.1.2.5 Market Sizing and Forecast
  • 2.1.3 Q Guidance System
    • 2.1.3.1 Overview
    • 2.1.3.2 Installed Base
    • 2.1.3.3 Average Selling Price
    • 2.1.3.4 Unit Sold
    • 2.1.3.5 Market Sizing and Forecast
  • 2.1.4 easyNav
    • 2.1.4.1 Overview
    • 2.1.4.2 Installed Base
    • 2.1.4.3 Average Selling Price
    • 2.1.4.4 Unit Sold
    • 2.1.4.5 Market Sizing and Forecast
  • 2.1.5 7D Surgical System
    • 2.1.5.1 Overview
    • 2.1.5.2 Installed Base
    • 2.1.5.3 Average Selling Price
    • 2.1.5.4 Unit Sold
    • 2.1.5.5 Market Sizing and Forecast
  • 2.1.6 Xvision-Spine System
    • 2.1.6.1 Overview
    • 2.1.6.2 Installed Base
    • 2.1.6.3 Average Selling Price
    • 2.1.6.4 Unit Sold
    • 2.1.6.5 Market Sizing and Forecast
  • 2.1.7 Caduceus S (AR)
    • 2.1.7.1 Overview
    • 2.1.7.2 Average Selling Price
    • 2.1.7.3 Unit Sold
    • 2.1.7.4 Market Sizing and Forecast
• 2.2 Stereotactic Frame Units

3 Global Stereotactic Neuro-navigation System Market (By Application), $Million, 2023-2035

• 3.1 Spinal
• 3.2 Cranial

4 Global Stereotactic Neuro-navigation System Market (By End User), $Million, 2023-2035

• 4.1 Hospitals and Clinics
• 4.2 Ambulatory Surgical Centers (ASCs)

5 Global Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

• 5.1 North America
  • 5.1.1 Regional Overview
  • 5.1.2 Driving Factors for Market Growth
  • 5.1.3 Factors Challenging the Market
  • 5.1.4 U.S.
  • 5.1.5 Canada
• 5.2 Europe
  • 5.2.1 Regional Overview
  • 5.2.2 Driving Factors for Market Growth
  • 5.2.3 Factors Challenging the Market
  • 5.2.4 U.K.
  • 5.2.5 Germany
  • 5.2.6 France
  • 5.2.7 Rest of the Europe
• 5.3 Asia Pacific
  • 5.3.1 Regional Overview
  • 5.3.2 Driving Factors for Market Growth
  • 5.3.3 Factors Challenging the Market
  • 5.3.4 Japan
  • 5.3.5 China
  • 5.3.6 Rest-of-Asia-Pacific
• 5.4 Rest-of-the-World
  • 5.4.1 Regional Overview
  • 5.4.2 Driving Factors for Market Growth
  • 5.4.3 Factors Challenging the Market

6 Markets - Competitive Benchmarking & Company Profiles

• 6.1 Key Strategies and Development
• 6.2 Product Benchmarking
• 6.3 Market Share
• 6.4 Company Profiles
  • 6.4.1 Medtronic Plc
    • 6.4.1.1 Overview
    • 6.4.1.2 Top Products/Product Portfolio
    • 6.4.1.3 Top Competitors
    • 6.4.1.4 Target Customers
    • 6.4.1.5 Key Personal
    • 6.4.1.6 Analyst View
  • 6.4.2 Brainlab AG
    • 6.4.2.1 Overview
    • 6.4.2.2 Top Products/Product Portfolio
    • 6.4.2.3 Top Competitors
    • 6.4.2.4 Target Customers
    • 6.4.2.5 Key Personal
    • 6.4.2.6 Analyst View
  • 6.4.3 ClearPoint Neuro, Inc.
    • 6.4.3.1 Overview
    • 6.4.3.2 Top Products/Product Portfolio
    • 6.4.3.3 Top Competitors
    • 6.4.3.4 Target Customers
    • 6.4.3.5 Key Personal
    • 6.4.3.6 Analyst View
  • 6.4.4 Elekta
    • 6.4.4.1 Overview
    • 6.4.4.2 Top Products/Product Portfolio
    • 6.4.4.3 Top Competitors
    • 6.4.4.4 Target Customers
    • 6.4.4.5 Key Personal
    • 6.4.4.6 Analyst View
  • 6.4.5 Stryker Corporation
    • 6.4.5.1 Overview
    • 6.4.5.2 Top Products/Product Portfolio
    • 6.4.5.3 Top Competitors
    • 6.4.5.4 Target Customers
    • 6.4.5.5 Key Personal
    • 6.4.5.6 Analyst View
  • 6.4.6 Orthofix Medical Inc
    • 6.4.6.1 Overview
    • 6.4.6.2 Top Products/Product Portfolio
    • 6.4.6.3 Top Competitors
    • 6.4.6.4 Target Customers
    • 6.4.6.5 Key Personal
    • 6.4.6.6 Analyst View
  • 6.4.7 SaphireX Surgicals
    • 6.4.7.1 Overview
    • 6.4.7.2 Top Products/Product Portfolio
    • 6.4.7.3 Top Competitors
    • 6.4.7.4 Target Customers
    • 6.4.7.5 Key Personal
    • 6.4.7.6 Analyst View
  • 6.4.8 FHC
    • 6.4.8.1 Overview
    • 6.4.8.2 Top Products/Product Portfolio
    • 6.4.8.3 Top Competitors
    • 6.4.8.4 Target Customers
    • 6.4.8.5 Key Personal
    • 6.4.8.6 Analyst View
  • 6.4.9 Integra LifeSciences Corporation
    • 6.4.9.1 Overview
    • 6.4.9.2 Top Products/Product Portfolio
    • 6.4.9.3 Top Competitors
    • 6.4.9.4 Target Customers
    • 6.4.9.5 Key Personal
    • 6.4.9.6 Analyst View
  • 6.4.10 SURGLASSES Inc.
    • 6.4.10.1 Overview
    • 6.4.10.2 Top Products/Product Portfolio
    • 6.4.10.3 Top Competitors
    • 6.4.10.4 Target Customers
    • 6.4.10.5 Key Personal
    • 6.4.10.6 Analyst View
  • 6.4.11 HRS Navigation
    • 6.4.11.1 Overview
    • 6.4.11.2 Top Products/Product Portfolio
    • 6.4.11.3 Top Competitors
    • 6.4.11.4 Target Customers
    • 6.4.11.5 Key Personal
    • 6.4.11.6 Analyst View
  • 6.4.12 Augmedics
    • 6.4.12.1 Overview
    • 6.4.12.2 Top Products/Product Portfolio
    • 6.4.12.3 Top Competitors
    • 6.4.12.4 Target Customers
    • 6.4.12.5 Key Personal
    • 6.4.12.6 Analyst View

7 Research Methodology

• 7.1 Data Sources
  • 7.1.1 Primary Data Sources
  • 7.1.2 Secondary Data Sources
  • 7.1.3 Data Triangulation
• 7.2 Market Estimation and Forecast